Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets
Francesca Racca, Gaia Pellegatta, Giuseppe Cataldo, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Meta‐Analysis: Inverse Association Between Helicobacter pylori Infection and Eosinophilic Oesophagitis
Irene Spinelli, Serena Porcari, Chiara Esposito, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 4
The epithelial barrier: The gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions
Duygu Yazıcı, İsmail Öğülür, Yağız Pat, et al.
Seminars in Immunology (2023) Vol. 70, pp. 101846-101846
Open Access | Times Cited: 28
Type 2 airway inflammation in COPD
Francesca Polverino, Don D. Sin
European Respiratory Journal (2024) Vol. 63, Iss. 5, pp. 2400150-2400150
Closed Access | Times Cited: 14
Systemic barrier dysfunction in type 2 inflammation diseases: perspective in the skin, airways, and gastrointestinal tract
Juan Meng, Hao Xiao, Feng Xu, et al.
Immunologic Research (2025) Vol. 73, Iss. 1
Open Access | Times Cited: 1
An update on the diagnosis and management of non‐IgE‐mediated food allergies in children
Rosan Meyer, Antonella Cianferoni, Marta Vázquez‐Ortiz
Pediatric Allergy and Immunology (2025) Vol. 36, Iss. 3
Closed Access | Times Cited: 1
Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms
Sara Massironi, Giacomo Mulinacci, Camilla Gallo, et al.
Cells (2023) Vol. 12, Iss. 20, pp. 2473-2473
Open Access | Times Cited: 22
Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice
Mauro Mormile, Ilaria Mormile, Salvatore Fuschillo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7254-7254
Open Access | Times Cited: 21
Fibrous Remodeling in Eosinophilic Esophagitis: Clinical Facts and Pathophysiological Uncertainties
Laura Arias‐González, Leticia Rodríguez-Alcolado, Emilio J. Laserna‐Mendieta, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 927-927
Open Access | Times Cited: 7
The Gut Microbiome and Its Implication in the Mucosal Digestive Disorders
Laura Bozomitu, Ingrith Miron, Anca Adam Răileanu, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3117-3117
Open Access | Times Cited: 24
Diagnosis and management of eosinophilic esophagitis
Milli Gupta, Michelle Grinman
Canadian Medical Association Journal (2024) Vol. 196, Iss. 4, pp. E121-E128
Open Access | Times Cited: 5
Eosinophilic Esophagitis—What Do We Know So Far?
Jakub Wąsik, Ewa Małecka‐Panas
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2259-2259
Open Access | Times Cited: 11
Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review
Giulia Migliorisi, Elisabetta Mastrorocco, Arianna Dal Buono, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4119-4119
Open Access | Times Cited: 4
Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the phase 3, randomized, placebo-controlled, LIBERTY EoE TREET trial
Albert J. Bredenoord, Evan S. Dellon, Christoph Schlag, et al.
Expert Review of Gastroenterology & Hepatology (2025), pp. 1-13
Open Access
Dupilumab in Atopic Children with Eosinophilic Esophagitis: A Case Series
Alireza Maleki, Stéphanie Willot, Bertrand Lioger, et al.
Deleted Journal (2025), pp. 100034-100034
Open Access
Investigating accumulation of budesonide and tacrolimus in an ex vivo porcine oesophageal model: translational potential for local application of drugs to treat eosinophilic oesophagitis
Farhan Taherali, Mitchell E. Taub, Felipe Varum, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107086-107086
Open Access
The Modulation of Cell Plasticity by Budesonide: Beyond the Metabolic and Anti-Inflammatory Actions of Glucocorticoids
Eduardo J. Patriarca, Cristina D’Aniello, Dario De Cesare, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 504-504
Open Access
Eosinophilic esophagitis patients report substantial disease burden comparable to more systemic immune-mediated diseases
Eva Theswet, Cosima Brucker, Andrea Kreienbühl, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Investigation of the mechanism by which miR-223-3p inhibits reflux esophagitis through targeting the NLRP3 inflammasome
Shuying Lin, Binbin Zheng-Lin, Ronald Wu, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Eosinophil-targeted treatment strategies for long-term outcomes in severe eosinophilic asthma
Giulia Pelaia, Vincenzo Aiello, Caterina Tinello, et al.
Expert Review of Respiratory Medicine (2025)
Closed Access
Multi-trait Analysis of GWAS Expands Eosinophilic Esophagitis Genetic Susceptibility and Polygenic Risk Scores
Michael P. Trimarchi, Bahram Namjou, Netali Ben-Baruch Morgenstern, et al.
(2025)
Closed Access
Future of therapy and monitoring for eosinophilic esophagitis and eosinophilic gastrointestinal diseases
Andrew Dickerson, Evan S. Dellon, Seema S. Aceves
Annals of Allergy Asthma & Immunology (2025)
Closed Access
Current state of biologics in treating eosinophilic esophagitis
Quan M. Nhu, Seema S. Aceves
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 1, pp. 15-20
Open Access | Times Cited: 16
Eosinophils in the Gastrointestinal Tract: Key Contributors to Neuro-Immune Crosstalk and Potential Implications in Disorders of Brain-Gut Interaction
Eloísa Salvo‐Romero, Bruno K. Rodiño‐Janeiro, Mercé Albert-Bayo, et al.
Cells (2022) Vol. 11, Iss. 10, pp. 1644-1644
Open Access | Times Cited: 15
Eosinophilic esophagitis and esophageal microbiota
Xiaohan Zhang, Nana Zhang, Zikai Wang
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 9
Vernal keratoconjunctivitis and eosinophilic esophagitis: A rare combination?
Maria Cristina Artesani, Sara Urbani, Carla Riccardi, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 1, pp. 100855-100855
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top